Manchurian baby's-breath
Gypsophila oldhamiana
Gypsophila oldhamiana is a flowering plant traditionally used in few documented practices. Scientific studies have identified two new C-glucofuranosyl flavones from its flowers, which showed no significant cytotoxic activities against cancer cell lines. However, one of these compounds, Oldhamianoside II, was found to inhibit prostate cancer progression by regulating EMT and Wnt/β-catenin signaling pathways. Additionally, extracts from the plant have demonstrated some antiangiogenic activity in roots, and an extract reduced acute Toxoplasma gondii parasite burden in mice by modulating DC-IL-12-CD8⁺ T cell axis. Safety concerns are currently minimal, with no major issues recorded. There is also no evidence of significant drug interactions at this time.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- The study identified two new C-glucofuranosyl flavones from Gypsophila oldhamiana flowers but found no significant cytotoxic activities against tested cancer cell lines.
- Oldhamianoside II inhibits prostate cancer progression by regulating EMT and Wnt/β-catenin signaling.
- GO extract reduced acute Toxoplasma gondii parasite burden in mice by modulating DC-IL-12-CD8⁺ T cell axis.
- Two new triterpenoids were identified from Gypsophila oldhamiana roots, along with known compounds, showing some antiangiogenic activity.
- The complete chloroplast genome of Gypsophila oldhamiana was sequenced and analyzed, revealing its structure and phylogenetic relationships.
Frequently asked questions
What is Manchurian baby's-breath?
Manchurian baby's-breath (Gypsophila oldhamiana) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Manchurian baby's-breath?
5 sourced findings are recorded for Manchurian baby's-breath; the strongest carries evidence grade D. For example: The study identified two new C-glucofuranosyl flavones from Gypsophila oldhamiana flowers but found no significant cytotoxic activities against tested cancer cell lines.
How strong is the evidence for Manchurian baby's-breath?
The strongest finding for Manchurian baby's-breath carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Manchurian baby's-breath safe? What are the side effects?
No major safety issues are recorded for Manchurian baby's-breath in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Manchurian baby's-breath interact with medications?
No drug interactions are recorded for Manchurian baby's-breath in our sources. This does not rule them out — check with a pharmacist.
Is Manchurian baby's-breath a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Two new triterpenoids from Gypsophila oldhamiana. literature abstract metadata
- T2 Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β-catenin signaling pathway. literature abstract metadata
- T2 Complete chloroplast genome of Gypsophila oldhamiana Miq. (Caryophyllales: Caryophyllaceae). literature abstract metadata
- T2 A pair of diastereoisomeric C-glucofuranosyl flavones from the flowers of Gypsophila oldhamiana. literature abstract metadata
- T2 Prophylactic Administration of Gypsophila oldhamiana Extract Restricts Acute Toxoplasma gondii Infection via the DC-IL-12-CD8⁺ T Cell Axis in a Murine Model. literature abstract metadata